$56.56
-0.77 (-1.33%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-8.92%
YTD
+5.19%
Open$58.00
Previous Close$57.33
Day High$59.34
Day Low$55.63
52W High$78.48
52W Low$44.12
Volume—
Avg Volume1.55M
Market Cap5.54B
P/E Ratio—
EPS$-4.76
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.19
Above
SMA 200
$54.12
Above
RSI (14)
52.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
28 analysts
Price Target
+96.4% upside
Current
$56.56
$56.56
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.82M | 2.67M | 1.10B |
| Net Income | -633,827,795 | -398,884,704 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -703,025,923 | -467,012,535 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |